• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cost-benefit analysis of neonatal intensive care for infants weighing less than 1,000 grams at birth.

作者信息

Walker D J, Feldman A, Vohr B R, Oh W

出版信息

Pediatrics. 1984 Jul;74(1):20-5.

PMID:6234507
Abstract

Cost-benefit analysis was performed on the care of 247 infants weighing between 500 and 999 g at birth, admitted to Women and Infants Hospital of Rhode Island between January 1977 and December 1981. The neonatal mortality was 68%. Eighty-seven percent of the survivors were evaluated neurodevelopmentally for 1 to 5 years: 74% were normal or minimally impaired, 10% were moderately impaired, and 16% were severely handicapped. Using these data in conjunction with cost information obtained from the hospital and therapeutic care facilities for handicapped children, total lifetime costs for the care of these infants were estimated. In 1982 dollars, present values of costs ranged from $362,992 per survivor for those weighing between 600 and 699 g to $40,647 per survivor for those weighing between 900 and 999 g, resulting in an inverse correlation between cost per survivor and birth weight (P less than .001). We estimated present values of expected lifetime earnings per survivor, with a range of zero earnings for infants between 500 and 699 g, to $77,084 for those with birth weight of 900 to 999 g. It is concluded that from the standpoint of cost-benefit analysis as was used for this study population, neonatal intensive care may not be justifiable for infants weighing less than 900 g at birth.

摘要

相似文献

1
Cost-benefit analysis of neonatal intensive care for infants weighing less than 1,000 grams at birth.
Pediatrics. 1984 Jul;74(1):20-5.
2
Economic analysis of regionalized neonatal care for very low-birth-weight infants in the state of Rhode Island.
Pediatrics. 1985 Jul;76(1):69-74.
3
Economic evaluation of neonatal intensive care of very-low-birth-weight infants.极低出生体重儿新生儿重症监护的经济学评估。
N Engl J Med. 1983 Jun 2;308(22):1330-7. doi: 10.1056/NEJM198306023082206.
4
Preterm birth-associated cost of early intervention services: an analysis by gestational age.早产相关的早期干预服务成本:按孕周分析
Pediatrics. 2007 Apr;119(4):e866-74. doi: 10.1542/peds.2006-1729. Epub 2007 Mar 5.
5
Neonatal intensive care and cost effectiveness.新生儿重症监护与成本效益。
CMAJ. 1988 Nov 15;139(10):943-6.
6
Survival chances of low birth weight infants in a rural hospital in Ghana.加纳一家乡村医院中低体重婴儿的存活几率。
Trop Geogr Med. 1994;46(5):313-7.
7
Cost-analysis of neonatal intensive and special care.
Aust Paediatr J. 1989 Apr;25(2):61-5.
8
The cost of care of the less-than-1000-gram infant.体重不足1000克婴儿的护理费用。
Clin Perinatol. 1986 Jun;13(2):461-76.
9
Variations in costs for the care of low-birth-weight infants among academic hospitals.学术医院中低体重儿护理成本的差异。
Clin Pediatr (Phila). 2010 May;49(5):443-9. doi: 10.1177/0009922809341750. Epub 2009 Jul 30.
10
Favorable results of neonatal intensive care for very low-birth-weight infants.极低出生体重儿新生儿重症监护的良好结果。
Pediatrics. 1982 May;69(5):621-5.

引用本文的文献

1
Curosurf surfactant application on preterm babies with respiratory complications-health-economic benefits.珂立苏表面活性物质在伴有呼吸并发症的早产儿中的应用-健康经济效益。
Afr Health Sci. 2024 Mar;24(1):220-227. doi: 10.4314/ahs.v24i1.27.
2
The price of neonatal intensive care outcomes - in-hospital costs of morbidities related to preterm birth.新生儿重症监护结果的代价——与早产相关疾病的住院费用。
Front Pediatr. 2023 Feb 7;11:1068367. doi: 10.3389/fped.2023.1068367. eCollection 2023.
3
Cost of neonatal intensive care for extremely preterm infants in Canada.
加拿大极早产儿新生儿重症监护的费用。
Transl Pediatr. 2021 Jun;10(6):1630-1636. doi: 10.21037/tp-21-36.
4
Regional variation in cost of neonatal intensive care for extremely preterm infants.极早产儿新生儿重症监护的成本存在地域差异。
BMC Pediatr. 2021 Mar 17;21(1):134. doi: 10.1186/s12887-021-02600-8.
5
Predicting the future for newborns requiring intensive care.预测需要重症监护的新生儿的未来。
Hum Nat. 1994 Mar;5(1):95-102. doi: 10.1007/BF02692193.
6
The long-term prognosis of pre-term infants: conceptual, methodological, and ethical issues.早产儿的长期预后:概念、方法和伦理问题。
Hum Nat. 1994;5(1):103-26. doi: 10.1007/BF02692194.
7
Colfosceril palmitate. A pharmacoeconomic evaluation of a synthetic surfactant preparation (Exosurf Neonatal) in infants with respiratory distress syndrome.棕榈酸考福斯昔尔。对患有呼吸窘迫综合征的婴儿使用一种合成表面活性剂制剂(Exosurf Neonatal)的药物经济学评估。
Pharmacoeconomics. 1994 Dec;6(6):563-77. doi: 10.2165/00019053-199406060-00009.
8
Cost effectiveness of beractant in the prevention of respiratory distress syndrome.
Pharmacoeconomics. 1993 Oct;4(4):278-86. doi: 10.2165/00019053-199304040-00006.
9
The economics and cost-effectiveness of critical care medicine.重症监护医学的经济学与成本效益
Intensive Care Med. 1995 Nov;21(11):952-61. doi: 10.1007/BF01712339.
10
The cost of neonatal care: reviewing the evidence.
Soz Praventivmed. 1995;40(6):361-8. doi: 10.1007/BF01325418.